Abdi T. Gudina

Abdi T. Gudina

Auto-generated profile, based on publicly available information

Abdi T. Gudina

Department of Public Health Sciences at the University of Rochester School of Medicine and Dentistry, Rochester, New York

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Cancer Epidemiology
Verified
Journal Article
Closed access
AGAbdi T. Gudina
Abdi T. Gudina
VCVinay K. Cheruvu
Vinay K. Cheruvu
NGNikesha J. Gilmore
Nikesha J. Gilmore
AKAmber S. Kleckner
Amber S. Kleckner
EAEvelyn Arana-Chicas
Evelyn Arana-Chicas
ACAna Paula Cupertino
Ana Paula Cupertino

13 September 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
AGAbdi T. Gudina
Abdi T. Gudina
CKCharles Kamen
Charles Kamen
Kelly A. HirkoKelly A. Hirko
Kelly A. Hirko
DADavid H. Adler
David H. Adler
DODeborah Ossip
Deborah Ossip
AMAlejandra mendoza
Alejandra mendoza
Background: Scanning with low-dose computed tomography reduces lung cancer mortality by 20% among high-risk individuals. Despite its efficacy, the uptake of lung cancer screening (LCS) remains low. Our study aimed to estimate state-level and nationwide LCS rates among eligible individuals and to assess disparities in LCS uptake. Methods: Data for this study were obtained from the 2022 Behavioral Risk Factor Surveillance System. Multivariable logistic regression models were used to model the associations between predictors and outcome variables and to examine LCS variability across states. Results: Of the 28,071 participants eligible for LCS, 17.24% underwent LCS. Participants ages 65 to 79 years were [OR, 1.75; 95% confidence interval (CI), 1.54–1.99] more likely to undergo LCS than their younger counterparts. Those who were female (OR, 0.83; 95% CI, 0.73–0.94); divorced, separated, or widowed (OR, 0.85; 95% CI, 0.74–0.98); without health insurance (OR, 0.34; 95% CI, 0.22–0.53); without a primary care provider (OR, 0.29; 95% CI, 0.19–0.44); and without chronic obstructive pulmonary disease or those who did not disclose their chronic obstructive pulmonary disease status (OR, 0.35; 95% CI, 0.31–0.40 and OR, 0.37; 95% CI, 0.19–0.73, respectively) were less likely to undergo LCS than their respective counterparts. LCS uptake also varied significantly across U.S. states. Conclusions: We observed a low uptake of LCS overall and significant variability in LCS uptake by sociodemographic and health-related factors, as well as by state of residence. Impact: The findings from this study have important implications for community health workers and healthcare clinicians and indicate the need to design effective interventions to increase LCS uptake, targeting specific subgroups of populations and particular U.S. states. See related In the Spotlight, p. 9

1 May 2023 in Journal Of Health Care For The Poor and Underserved
Verified
Journal Article
Closed access
PDF file
AGAbdi T. Gudina
Abdi T. Gudina
CKCharles Kamen
Charles Kamen
VCVinay K. Cheruvu
Vinay K. Cheruvu
PCPaula Cupertino
Paula Cupertino
MRM. Patricia Rivera
M. Patricia Rivera
Early detection using low-dose computed tomography scanning reduces lung cancer-specific mortality by 20% among high-risk individuals. Despite its efficacy, the uptake of lung cancer screening (LCS) remains low. This study aimed to identify factors associated with the uptake of LCS in high-risk individuals. Data for this study were obtained from the Behavioral Risk Factor Surveillance System (n=11,297). Multivariable logistic regression models were used. Individuals with no health insurance (OR: 0.33, 95% CI: 0.19-0.58), no primary health care provider (OR: 0.40, 95% CI: 0.25-0.64), no chronic obstructive pulmonary disease (OR: 0.37, 95% CI: 0.28- 0.49), and racial/ethnic minorities other than Black and Hispanic (OR: 0.49, 95% CI: 0.31-0.78) were less likely to participate in annual LCS. Low-dose computed tomography uptake varied widely across the 24 U.S. states. The findings from this study have important implications for designing more effective interventions to target specific U.S. states and subgroups for the uptake of annual LCS.

9 June 2022 in Patient Education and Counseling
Verified
Journal Article
Closed access
LKLee A. Kehoe
Lee A. Kehoe
CSChandrika Sanapala
Chandrika Sanapala
GDGrace DiGiovanni
Grace DiGiovanni
RYReza Yousefi-Nooraie
Reza Yousefi-Nooraie
SYSule Yilmaz
Sule Yilmaz
RERonald M. Epstein
Ronald M. Epstein

20 March 2024 in Lung Cancer
Verified
Journal Article
Closed access
AGAbdi T. Gudina
Abdi T. Gudina
CKCharles Kamen
Charles Kamen
SHSara J Hardy
Sara J Hardy
LKLee Kehoe
Lee Kehoe
ECEva Culakova
Eva Culakova
ACAna-Paula Cupertino
Ana-Paula Cupertino

10 September 2024 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
LKLee A. Kehoe
Lee A. Kehoe
MSMichael B. Sohn
Michael B. Sohn
LWLu Wang
Lu Wang
SMSupriya Mohile
Supriya Mohile
CKCharles Kamen
Charles Kamen
KLKah Poh Loh
Kah Poh Loh